Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimer's Disease

E-ISSN： 1873-4294|8|12|1035-1048

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.12, 2008-08, pp. : 1035-1048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimer's Disease

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 139-145

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin 5-HT7 Receptor Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

By Slassi Abdelmalik Isaac Methvin O’Brien Anne

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 513-527

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 171-199

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: 5-HT4 Receptor Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 37-42

Bentham Science Publishers

Access to resources Recommend Favorite